Tot Biopharm, a private equity-backed Chinese biopharmaceutical company, has filed for an initial public offering (IPO) in Hong Kong on Monday under the rules that allow pre-profit companies to float shares on the stock exchange.

UNLOCK DATASubscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech